Speakers

Tricia Schumann is a serial entrepreneur engaged in the management and ownership of hyper-growth businesses for over three decades with a focus on healthcare in the past 15 years. Ms. Schumann has experience in a wide-range of healthcare sectors including venture capital, health plan, health system, digital health and telehealth, health IT, large group employer healthcare and life sciences. As an evangelist for healthcare innovation, she is passionate about empowering payers, providers and their patients with resources to improve access, affordability and outcomes. Tricia Schumann serves as Chief Investment Officer for Baiya Phytopharm. She serves on for-profit and non-profit boards including Centura Health, Ascellux, Blu Biotech, and Orriant. Ms. Schumann has experience in a wide-range of healthcare sectors including venture capital, health plan, health system, digital health and telehealth, health IT, and life sciences. She is passionate about empowering payers, providers and their patients with resources to improve access, affordability and outcomes. Ms. Schumann was named a "30 Women to Watch", is a Woman Tech Council finalist and a 2022 recipient of Top 50 Women in Finance in the U.S. 2022 and 2023 nominee. Ms. Schumann is a Harvard Business School alum and the Harvard Medical School Pre-Med HMX program.